General - Oncology
Payments companies reported to CMS as associated with General - Oncology. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with General - Oncology, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with General - Oncology
These are the largest totals companies reported as associated with General - Oncology. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Allaway | Cumberland, MD | Urology | $28,199.56 |
| Mitchell Humphreys | Phoenix, AZ | Urology | $11,108.76 |
| Daniel Frendl | Scottsdale, AZ | Urology | $9,035.13 |
| Jeffrey Spier | El Paso, TX | $6,400.00 | |
| Matthew Cavey | Fort Worth, TX | Radiation Oncology | $133.00 |
| Rafael Carrion | Tampa, FL | Urology | $114.60 |
| Raviender Bukkapatnam | Tampa, FL | Urology | $46.00 |
| Michael Trotter | Austin, TX | Urology | $45.78 |
| Tyler Mcclintock | Winchester, MA | Urology | $45.78 |
| Andrew Barger | Austin, TX | Gerontology (Clinical Nurse Specialist) | $45.78 |
Prescribed General - Oncology?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.